logo

Last Update

This profile was last updated on 2/6/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Sudhir Vaid?

Sudhir Vaid

Cmd

Concord Biotech Limited

HQ Phone:  +91 79 4032 1179

Email: s***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Concord Biotech Limited

1482-1486, Trasad Road, Dholka

Ahmedabad, Gujarat,387810

India

Company Description

Concord Biotech Ltd. is an R&D driven biotechnological powerhouse that manufactures Active Pharmaceutical Ingredients through the process of Fermentation, Semi-synthetic and synthetic processes. Founded in the year 2000, Concord has since emerged from a single...more

Web References(14 Total References)


Welcome to Concord Biotech

www.concordbiotech.com [cached]

Sudhir Vaid is the MD and CEO of Concord Biotech Limited.
He is responsible for ensuring efficient and effective functioning of the organization as a whole. As a promoter of Concord Biotech Limited, Sudhir is responsible for providing the strategic direction and is the keystone in building strategic partnerships and a strong and prestigious customer base for Concord. Sudhir began his career as a biotechnologist in the year 1975 and has worked with the leading biotechnology companies in India and abroad, before he turned entrepreneur in the year 2000. He brings with him a rich 30 years of experience in Corporate R & D and consultancy with the leading global API companies in the area of biotechnology encompassing vitamins, statins, hormones and antibiotics. He is a prolific observer with an open mind & a zeal for excellence. He has a keen determination to grow which has led Concord to achieving greater heights. With his vision & foresight Concord has come up to be one of the fastest growing global fermentation based API companies.


www.business-standard.com

Ankur Vaid, son of Concord Biotech's founder Sudhir Vaid, confirmed the Ahmedabad-based company's plans.
"Definitely, an IPO is in the pipeline," Vaid told Business Standard. He is also a director of Concord Biotech. "However, we have not yet decided the timeframe and the amount to be raised from the issue," he added. Vaid said Jhunjhunwala had a "significant stake" in Concord Biotech. According to media reports, Jhunjhunwala holds 40 per cent while Sudhir Vaid owns 52 per cent. Tags :IPOs | Rakesh Jhunjhunwala | Concord Biotech | Hungama Digital | Topsgrup | Ankur Vaid | Sudhir Vaid | Sebi |


BioSpectrumIndia - the business of biotech

www.biospectrumindia.com [cached]

- Sudhir Vaid, MD, Concord Biotech Ltd, Ahmedabad


Business News

www.deccan.com [cached]

Sudhir Vaid, the main promoter and managing director of Concord Biotech, signed a term sheet with Matrix executives in Secunderabad on Tuesday.Matrix sources said that Concord Biotech is a closely-held private company, which posted a net profit of Rs 2 crores on revenues of Rs 15 crores in 2004-05.Financial terms of the deal were not disclosed. Matrix will be acquiring the 55 per cent stake in Concord Biotech through a combination of purchasing of existing equity shares from the promoters and other shareholders of the company and subscribing to the new equity shares to be issued by Concord Biotech on preferential basis.Mr Sudhir Vaid and his associates will continue to hold a 29 per cent stake in the company.Other existing shareholders will hold a 16 per cent stake.The sources said that Mr Vaid and his team will continue to spearhead the operations of the company under the guidance of the board in which Matrix will have majority representation.Concord has filed Drug Master Files for Lovastatin, Simvastatin and Tacrolimus with the US FDA.Dossiers for obtaining Certificate of Suitability for these three products have also been filed with the European department for quality medicines.


domain-B: companies: companies : Matrix to acquire controlling stake in Concord Biotech

www.domain-b.com [cached]

Sudhir Vaid, the main promoter and the managing director of Concord Biotech, and his associates will continue to hold 29 per cent stake in the company.Other existing shareholders will hold a 16-per cent stake.Vaid and his team will continue to spearhead the operations of the Concord reporting to the board in which Matrix will have majority representation.In addition, Vaid will also enter into a non compete agreement with Matrix for three years, which would commence after the completion of the period of the management contract.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory